Seva - Clinical Research Professionals Inc is categorized under Medical Labs in Cupertino, CA and active since 2010.
Seva - Clinical Research Professionals Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Tengu Muna at the company’s single location by writing to 21109 Red Fir Court, Cupertino, California CA 95014 or by phoning (775) 343-8551. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Seva - Clinical Research Professionals Inc |
| Contact Person: | Tengu Muna |
| Address: | 21109 Red Fir Court, Cupertino, California 95014 |
| Phone Number: | (775) 343-8551 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Seva - Clinical Research Professionals Inc was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Tengu Muna for inquiries that concern Seva - Clinical Research Professionals Inc by calling the company number (775) 343-8551, as your correspondence is most welcome. Additionally, the physical location of the single location of Seva - Clinical Research Professionals Inc can be found at the coordinates as well as the street address 21109 Red Fir Court in Cupertino, California 95014.
For its online presence, you may visit Seva - Clinical Research Professionals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.